Answers are grounded in this paper and cite their sources.
Neuroblastomas are usually located in an area with poor oxygen supply inside the tumour; such an environment may promote metastasis and other serious behaviour in children. Tumor cells can switch between adrenergic and mesenchymal states to affect the clinical outcomes of young children.Hypoxia causes changes in the shape of cancer cells, the whole molecular signal pathway is still not known, and essential regulators that control these switches at different stages of cell growth have not been identified, Therefore,many crucial regulatory circuits still need to be studied. Based on the data of hypoxic cell lines, genetic knockdown assays and various molecular diagnostic methods were used to identify the metabolic pathways that cause structural changes in neuroblastoma under oxygen deprivation. HIF-2α is a switch that changes the expression pattern of the adrenergic signature genes into a mesenchymal one. PRRX1 and NOTCH3 are the secondary mediators that can decrease the production of native adrenergic mRNAs and promote the activation of a pro-tumorigenic mesenchymal feedback loop via HIF-2α. Currently, all of them are still at the level of laboratory cell culture and have not been validated by living mouse experiments or histopathological tests of real human tumour tissue. In the future, new technologies and a new biological model of rodents will be introduced into clinical trials to further verify the application of this model and enhance the development of HIF-2α-targeted drugs. This research provides a clear molecular basis for follow-up experimental exploration.
No takes yet. Share an insight, caveat, or question.
Weiwei Zhang (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: